Avalo Therapeutics Inc (AVTX): https://ih.advfn.com/stock-market/NASDAQ...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Avalo Therapeutics Inc (AVTX)

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	4045
Posts	152977
Boards Moderated	3
Alias Born	08/05/2009

Re: INV4 post# 634

Tuesday, 09/26/2023 7:09:49 AM

Tuesday, September 26, 2023 7:09:49 AM

https://ih.advfn.com/stock-market/NASDAQ/avalo-therapeutics-AVTX/stock-news/92125317/form-8-k-current-report

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent AVTX News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/12/2026 10:09:39 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 08:20:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:18:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:16:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:15:10 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:54:16 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:32:13 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:30:36 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:29:41 PM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/06/2026 03:00:55 PM
Avalo Therapeutics Announces Pricing of $375 Million Public Offering • GlobeNewswire Inc. • 05/06/2026 03:33:54 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/05/2026 08:28:31 PM
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 05/05/2026 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:01:30 PM
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa • GlobeNewswire Inc. • 05/05/2026 08:01:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:37:50 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/29/2026 08:33:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:01:21 AM
Avalo Therapeutics Purchases Optional Milestone Buyout • GlobeNewswire Inc. • 04/28/2026 11:00:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2026 08:02:49 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 08:01:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:51:43 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/06/2026 08:34:20 PM

More AVTX News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow